Moreover, our data show upregulation at proteome level of DCLK, a protein involved in tumorigenesis (Hayakawa et al, 2017), and JAK1, a protein involved in melanoma resistance against BRAFi (Kim et al, 2015; Dataset EV2). The gene discussed is DCLK1; the disease is melanoma.